Patents by Inventor Steven R. Turner

Steven R. Turner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8067589
    Abstract: The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts and solvates thereof, wherein the substituents are as defined herein, compositions containing such compounds and the uses of such compounds for the treatment of various diseases and conditions such as asthma.
    Type: Grant
    Filed: July 9, 2009
    Date of Patent: November 29, 2011
    Assignee: Pfizer Inc
    Inventors: Tanisha D. Blake, Bruce C. Hamper, Wei Huang, James R. Kiefer, Jr., Joseph B. Moon, Bradley E. Neal, Kirk L. Olson, Matthew J. Pelc, Barbara A. Schweitzer, Atli Thorarensen, John I. Trujillo, Steven R. Turner
  • Patent number: 7902373
    Abstract: The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts and solvates thereof, wherein the substituents are as defined herein, compositions containing such compounds and the uses of such compounds for the treatment of various diseases and conditions such as asthma.
    Type: Grant
    Filed: December 12, 2007
    Date of Patent: March 8, 2011
    Assignee: Pfizer Inc
    Inventors: Tanisha D. Blake, Bruce C. Hamper, Wei Huang, James R. Kiefer, Jr., Joseph B. Moon, Bradley E. Neal, Kirk L. Olson, Matthew J. Pelc, Barbara A. Schweitzer, Atli Thorarensen, John I. Trujillo, Steven R. Turner
  • Publication number: 20090281125
    Abstract: The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts and solvates thereof, wherein the substituents are as defined herein, compositions containing such compounds and the uses of such compounds for the treatment of various diseases and conditions such as asthma.
    Type: Application
    Filed: July 9, 2009
    Publication date: November 12, 2009
    Inventors: Tanisha D. Blake, Bruce C. Hamper, Wei Huang, James R. Kiefer, JR., Joseph B. Moon, Bradley E. Neal, Kirk L. Olson, Matthew J. Pelc, Barbara A. Schweitzer, Atli Thorarensen, John I. Trujillo, Steven R. Turner
  • Patent number: 7582643
    Abstract: The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts and solvates thereof, wherein the substituents are as defined herein, compositions containing such compounds and the uses of such compounds for the treatment of various diseases and conditions such as asthma.
    Type: Grant
    Filed: February 18, 2008
    Date of Patent: September 1, 2009
    Assignee: Pfizer Inc
    Inventors: Tanisha D. Blake, Bruce C. Hamper, Wei Huang, James R. Kiefer, Jr., Joseph B. Moon, Bradley E. Neal, Kirk L. Olson, Matthew J. Pelc, Barbara A. Schweitzer, Atli Thorarensen, John I. Trujillo, Steven R. Turner
  • Publication number: 20080207651
    Abstract: The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts and solvates thereof, wherein the substituents are as defined herein, compositions containing such compounds and the uses of such compounds for the treatment of various diseases and conditions such as asthma.
    Type: Application
    Filed: February 18, 2008
    Publication date: August 28, 2008
    Inventors: Tanisha D. Blake, Bruce C. Hamper, Wei Huang, James R. Kiefer, Joseph B. Moon, Bradley E. Neal, Kirk L. Olson, Matthew J. Pelc, Barbara A. Schweitzer, Atli Thorarensen, John I. Trujillo, Steven R. Turner
  • Publication number: 20080146569
    Abstract: The present invention relates to compounds of formula (I) and pharmaceutically acceptable salts and solvates thereof, wherein the substituents are as defined herein, compositions containing such compounds and the uses of such compounds for the treatment of various diseases and conditions such as asthma.
    Type: Application
    Filed: December 12, 2007
    Publication date: June 19, 2008
    Inventors: Tanisha D. Blake, Bruce C. Hamper, Wei Huang, James R. Kiefer, Joseph B. Moon, Bradley E. Neal, Kirk L. Olson, Matthew J. Pelc, Barbara A. Schweitzer, Atli Thorarensen, John I. Trujillo, Steven R. Turner
  • Patent number: 7333904
    Abstract: A processor is responsive to a thermistor temperature (Tth) adjacent a FET and to a drain-to-source voltage (VDS) of the FET. The processor stores the characteristics of the PET and a thermal model of the system hardware and uses a first set of equations to determine the temperature (TJ) at the junction of the PET in a stable region of operation where TJ?Tth is nearly constant. The processor is further responsive to a step change in successive measurements of VDS indicative of a lag of Tth relative to TJ. In this step-change region, the processor then resolves TJ based upon a second set of equations.
    Type: Grant
    Filed: August 26, 2005
    Date of Patent: February 19, 2008
    Assignee: Delphi Technologies, Inc.
    Inventors: Steven R. Turner, Mohammad Zakaria
  • Patent number: 7185782
    Abstract: A drinking device having a fluid-containing portion is provided. The fluid-containing portion includes a first end having an opening and a second end substantially opposed thereto. The opening in the first end of the fluid-containing portion is typically larger than the opening in the second end of the fluid-containing portion. The device also includes a holding member having a generally C-shaped channel therein. The device includes a flexible tubular member including a first end and a second end. The first end of the tubular member is connected to the opening in a second end of the fluid-containing portion. The second end of the flexible tubular member is in releasable communication with the C-shaped channel of the holding member.
    Type: Grant
    Filed: November 11, 2004
    Date of Patent: March 6, 2007
    Inventors: Brigido L. Vilchez, Jr., Steven R. Turner
  • Patent number: 6852731
    Abstract: The invention provides a compound of formula I: wherein G, R2, R3, and R4 have any of the values defined in the specification, or a pharmaceutically acceptable salt thereof, as well as processes and intermediates useful for preparing such compounds or salts, and methods of preventing or treating a herpesvirus infection using such compounds or salts.
    Type: Grant
    Filed: January 14, 2003
    Date of Patent: February 8, 2005
    Assignee: Pfizer
    Inventors: Scott D. Larsen, Paul May, Karen Romines, Mark E. Schnute, Steven P. Tanis, James A. Nieman, David John Anderson, Euibong J. Kim, Steven R. Turner
  • Publication number: 20040242884
    Abstract: The invention provides a compound of formula I: 1
    Type: Application
    Filed: January 14, 2003
    Publication date: December 2, 2004
    Inventors: Scott D. Larsen, Paul May, Karen Romines, Mark E. Schnute, Steven P. Tanis, James A. Nieman, David John Anderson, Euibong J. Kim, Steven R. Turner